Ozempic (semaglutide), is a GLP-1 receptor agonist approved initially for Type 2 diabetes treatment, which is now conventional medicine's solution for weight loss. Semaglutide's meteoric rise is attributed to its powerful appetite-suppressing effects and impressive...